聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 1 小时 9 分钟 前

Interpace Diagnostics Announces New Coding by Novitas Solutions for PancraGen(TM)

周一, 04/18/2016 - 14:40
New Code Expected to Improve Reimbursement PARSIPPANY, N.J., April 18, 2016 -- (Healthcare Sales & Marketing Network) -- Interpace Diagnostics Group (IDXG) a company that provides clinically useful molecular diagnostic tests and pathology services for ...
Diagnostics, Oncology, Reimbursement
Interpace Diagnostics, PancraGen, pancreatic cyst, pancreatic cancer

Joseph Horrigan Joins AMO Pharma as Chief Medical Officer

周一, 04/18/2016 - 14:35
Company further expands leadership team with new VP of Clinical Operations and Head of Pharmaceutical Science and Manufacturing LONDON and PHILADELPHIA, April 18, 2016 -- (Healthcare Sales & Marketing Network) -- AMO Pharma Limited ("AMO Pharma&qu...
Biopharmaceuticals, Personnel
AMO Pharma, fragile X syndrome, myotonic dystrophy

Elekta and Philips Begin Installation of MR-Guided Linear Accelerator at The Netherlands Cancer Institute

周一, 04/18/2016 - 14:33
Event marks continued progress in global consortium's effort to improve patient outcomes through real-time clinical imaging and precise treatment delivery AMSTERDAM, April 18, 2016 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST), Royal ...
Devices, Oncology, Radiology
Elekta, Royal Philips, magnetic resonance, linear accelerator, radiotherapy

AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals

周五, 04/15/2016 - 13:42
95 percent of patients achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with and without RBV in GT1 chronic HCV infected patients without cirrhosis who failed previous therapy with DAAs in a modified intent-to-treat analysis 91 percent achieved SVR12...
Biopharmaceuticals
AbbVie, hepatitis C, MAGELLAN-1, ABT-493, ABT-530

AbbVie Announces Real-World Data with VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA(R) (dasabuvir tablets) from Large German Hepatitis C-Registry

周五, 04/15/2016 - 13:34
VIEKIRAX and EXVIERA achieved 96 percent SVR12 in genotype 1 and 100 percent in genotype 4 chronic hepatitis C virus infected patients in a large ongoing real-world study(1) Data support findings from previous HCV Phase 3 clinical trials with VIEKIRAX a...
Biopharmaceuticals
AbbVie, hepatitis C, VIEKIRAX, EXVIERA

RefleXion Medical Raises $46 Million Series B Financing Led by KCK Group

周四, 04/14/2016 - 13:57
Financing Will Support Commercialization of the First Biology-Guided Radiotherapy System for Targeted, Personalized Cancer Treatment HAYWARD, CA--(Healthcare Sales & Marketing Network) - RefleXion Medical, a medical equipment company developing the fir...
Devices, Oncology, Venture Capital, Personnel
RefleXion Medical, biology-guided radiotherapy, radiotherapy

Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company

周四, 04/14/2016 - 13:51
Combined Company Well-Funded to Generate Data from Multiple Phase 2 Studies Paul A. Friedman, M.D. Named Chairman and Chief Executive Officer of Combined Company Companies to Host Conference Call and Webcast Today, April 14, at 8:30 AM ET LEXINGTO...
Biopharmaceuticals, Mergers & Acquisitions
Synta Pharmaceuticals, Madrigal Pharmaceuticals

New Analyses of the Phase 3 POISE Trial of Ocaliva(TM) (Obeticholic Acid) for the Treatment of PBC Presented at EASL

周四, 04/14/2016 - 13:42
NEW YORK, April 14, 2016 -- (Healthcare Sales & Marketing Network) -- Intercept Pharmaceuticals, Inc. (ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat non-viral, progressive ...
Biopharmaceuticals
Intercept Pharmaceuticals, Ocaliva, obeticholic acid, biliary cholangitis

Lumos Pharma Appoints David M. Weiner, M.D. as Chief Medical Officer

周三, 04/13/2016 - 15:12
AUSTIN, Texas, April 13, 2016 -- (Healthcare Sales & Marketing Network) -- Lumos Pharma, Inc., a biotechnology company focused on bringing novel therapies to patients with unmet medical needs in severe, rare, and genetic diseases, announced that David M. ...
Biopharmaceuticals, Personnel
Lumos Pharma, Creatine Transporter Deficiency

Impax Announces Availability of EMVERM(TM) (mebendazole) Chewable Tablets, 100 mg

周三, 04/13/2016 - 15:09
EMVERM Provides a New Option for Patients with Pinworm, Whipworm, Roundworm and Hookworm in Single or Mixed Infections HAYWARD, Calif., April 13, 2016 -- (Healthcare Sales & Marketing Network) -- Impax Laboratories, Inc. (IPXL)today announced that EMVE...
Biopharmaceuticals, Product Launch
Impax Laboratories, EMVERM, mebendazole

Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors

周三, 04/13/2016 - 15:06
HALIFAX, NOVA SCOTIA--(Healthcare Sales & Marketing Network) - Immunovaccine Inc. ("Immunovaccine" or the "company") (IMV.TO)(IMMVF), a clinical stage vaccine and immunotherapy company, today announced that Frederic Ors has been appoint...
Biopharmaceuticals, Personnel
Immunovaccine, DepoVax

Oculus Innovative Sciences Receives European Approval to Market Sinudox(TM) Indicated for Use in Nasal Irrigation

周三, 04/13/2016 - 15:03
PETALUMA, Calif., April 13, 2016 -- (Healthcare Sales & Marketing Network) -- Oculus Innovative Sciences, Inc. (OCLS) (OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advance...
Biopharmaceuticals, Regulatory
Oculus Innovative Sciences, Sinudox, Microcyn

Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer

周三, 04/13/2016 - 15:00
REDWOOD CITY, CA--(Healthcare Sales & Marketing Network) - Autonomic Technologies, Inc. (ATI) today announced the appointment of Niamh Pellegrini to the position of President and Chief Executive Officer and member of its board of directors. In this role, M...
Devices, Neurology, Personnel
Autonomic Technologies, Pulsante, cluster headache

Richard Hausmann Appointed as Elekta's President and CEO

周三, 04/13/2016 - 14:58
STOCKHOLM, April 13, 2016 -- (Healthcare Sales & Marketing Network) -- Elekta's (EKTA-B.ST) Board of Directors has appointed Richard Hausmann, to lead the company effective June 10, 2016. He will succeed Tomas Puusepp, current President and Chief Executiv...
Devices, Oncology, Neurosurgery, Personnel
Elekta, Leksell, Gamma Knife, radiosurgery, radiotherapy

Expanding Orthopedics Inc. Announces that Mr. Dale Binke Joins Company's Management as Vice President of US Sales

周二, 04/12/2016 - 15:55
Industry veteran to join EOI to lead and develop growing US Sales OR AKIVA, Israel, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- Expanding Orthopedics Inc. (EOI), a privately held medical device company focused on developing and commerci...
Devices, Orthopaedic, Neurosurgery, Personnel
Expanding Orthopedics

AQUACEL(R) Foam Pro Dressing to be featured at Spring SAWC

周二, 04/12/2016 - 15:52
Newest addition to AQUACEL®portfolio uses Hydrofiber®Technology to protect sacral skin from breakdown LUXEMBOURG, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- ConvaTec, a leading global medical products and technologies company, ...
Devices, Wound Care
ConvaTec, AQUACEL

iSTAR Medical Secures €10 Million Financing

周二, 04/12/2016 - 13:17
Funding Supports Product Development and CE-marking clinical study for Breakthrough Glaucoma Implant WAVRE, Belgium, April 12, 2016 -- (Healthcare Sales & Marketing Network) -- iSTAR Medical SA, a private medical device company developing novel ophthal...
Devices, Ophthalmology, Venture Capital
iSTAR Medical, MINIject, MIGS device

Autonomic Technologies Appoints Niamh Pellegrini as President and Chief Executive Officer

周二, 04/12/2016 - 13:06
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Autonomic Technologies, Inc. (ATI) today announced the appointment of Niamh Pellegrini to the position of President and Chief Executive Officer and member of its board of directors. In this role...
Devices, Neurology, Personnel
Autonomic Technologies, Pulsante Microstimulator, cluster headache

AtriCure Announces 510(k) Clearance for the cryoFORM(TM) Cryoablation Probe

周二, 04/12/2016 - 12:59
Clearance brings an even more flexible probe to the U.S. market for use in a variety of surgical interventions to treat cardiac arrhythmias. Product was launched in Europe in October 2015 MASON, Ohio--(Healthcare Sales & Marketing Network)--AtriCure,...
Devices, Interventional, Cardiology, FDA
AtriCure, atrial fibrillation, cryoFORM, cryoablation

Elite Pharmaceuticals Announces Changes to their Board of Directors

周二, 04/12/2016 - 12:53
Gene Pfeifer Joins Elite’s Board NORTHVALE, N.J., April 12, 2016 -- (Healthcare Sales & Marketing Network) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (ELTP) announced today that its Board of Directors has appointed Eugene P...
Biopharmaceuticals, Personnel
Elite Pharmaceuticals

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong